Press release
Neuropathic Pain Market Growth Factors and Manufacturers
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would be the trend followed by the physical therapy market going forward.
Get Free Sample Copy Of Neuropathic Pain Market Report@ https://www.persistencemarketresearch.com/samples/4149
Reaching the revenues of over US$ 6 Bn at the end of 2019, the global neuropathic pain management market is projected for a healthy CAGR during the forecast period (2019 - 2029). Increasing prevalence of neuropathic pain disorders and growing awareness about pain medication are boosting the demand for pain management drugs.
Pipeline strategies by manufacturers are focused on introducing advanced drugs with minimum side effects to increase market share. For instance, Pfizer sponsored drug Pregabalin, effective in treating neuropathic (nerve) pain resulting from peripheral nerve trauma that is in phase 3 clinical trials. Increasing research and development activities to develop medications for indications such as post-herpetic neuralgia are creating significant opportunities for manufactures to flourish in the market.
Company Profiles
• Pfizer Inc.
• Johnson & Johnson Services, Inc.
• Bristol-Myers Squibb Company
• Sanofi S.A
• GlaxoSmithKline plc
• Eli Lilly and Company
• Teva Pharmaceutical Industries Ltd
• Baxter International Inc
How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Neuropathic Pain Market? https://www.persistencemarketresearch.com/methodology/4149
Key Takeaways - Neuropathic Pain Management Market Study
• Attributed to less side effects, tricyclic antidepressant drugs are expected to be popular as compared to opioids and steroids during the forecast period.
• North America is expected to be significant revenue generator owing to emergence of several regional market players and well-developed healthcare infrastructure.
• Retail pharmacies are expected to be dominant distribution channels in the neuropathic pain management market.
Increasing prevalence of diabetic neuropathy and availability of approved neuropathy pain medications have significantly added to the opportunities for market growth, thereby fostering the rate of adoption of neuropathic pain management drugs.
Increasing R&D Spending by Pharmaceuticals Companies Shaping Future
One of the key factors observed to impact the neuropathic pain management market growth is the development of new drugs for treatment of neuropathic and chronic pains. Companies are focusing on clinical trials to develop drugs for efficient treatment of neuropathic pain. For instance, Eli Lilly and Company developed Duloxetine (LY248686) for Diabetic Peripheral Neuropathic Pain (DPNP) that is under phase 4 clinical trial.
Go To "Purchase Now" To Have Our Neuropathic Pain Market Report! https://www.persistencemarketresearch.com/checkout/4149
At the same time, companies are focused on expanding therapeutic applications of drugs such as opioids and steroids for neuropathic pain management without causing any serious side effects to patients. Currently, more than 100 clinical trials are been carried out for pain management. Among those clinical trials, nearly half of the clinical trials are for various indications of neuropathic pain such as diabetic neuropathy and post-herpetic neuralgia.
What Does the Report Cover?
The neuropathic pain management market, a new study from Persistence Market Research, provides unparalleled insights on evolution of the neuropathic pain management market during 2014 - 2018 and presents demand projections during 2019 - 2029 on the basis of drug class (tricyclic anti-depressants, anticonvulsants, SNRI's, capsaicin cream, local anesthesia, opioids, steroids, and others), indication (diabetic neuropathy, trigeminal neuralgia, post-herpetic neuralgia, chemotherapy-induced peripheral neuropathy and others), distribution channel (retail pharmacies, hospital pharmacies, and online pharmacies) across prominent regions (North America, Latin America, Europe, Asia Pacific and MEA).
Contact us:
Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
About Us :-
Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuropathic Pain Market Growth Factors and Manufacturers here
News-ID: 2736207 • Views: …
More Releases from Persistence Market Research
HIV AIDS Testing Market Sales Estimated to Hit USD 6.6 Billion by 2032| Says Per …
Introduction
The HIV AIDS testing market has gained significant importance in recent years due to the global focus on early diagnosis, prevention, and management of HIV infections. Timely and accurate testing plays a crucial role in reducing transmission rates, improving patient outcomes, and supporting public health initiatives worldwide. With advancements in diagnostics, including rapid tests, ELISA, and molecular assays, HIV testing has become more accessible, reliable, and efficient across healthcare settings.
For…
Urinary Catheters Market to Surge at 5.6% CAGR, Hitting US$ 3.1 Bn by 2032, Acco …
Introduction
The urinary catheters market has witnessed significant growth in recent years, driven by its essential role in managing urinary retention, incontinence, surgical interventions, and other urological disorders. Urinary catheters are widely used across hospitals, long-term care facilities, and home healthcare settings due to their effectiveness in draining urine from the bladder and supporting patients with chronic or temporary urinary complications. Known for their clinical importance, adaptability, and availability in various…
3D Bioprinting Market Size is Expected to Reach 7.39 Billion by 2032, Rising at …
Introduction
The 3D bioprinting market has gained significant momentum in recent years due to its transformative potential in healthcare, pharmaceutical research, and regenerative medicine. Known for its ability to precisely fabricate complex biological structures, 3D bioprinting is widely applied in areas such as tissue engineering, organ regeneration, drug testing, and personalized medicine. By enabling the creation of living tissues with high accuracy, this technology is revolutionizing research capabilities and paving the…
Viral Molecular Diagnostic Market to Grow at a CAGR of 9.0% from 2025 to 2032, r …
Introduction
The viral molecular diagnostic market has gained substantial traction in recent years due to its critical role in the accurate detection and management of viral infections. Known for their precision, speed, and ability to identify genetic material of viruses, molecular diagnostic tests are widely used across healthcare facilities, research laboratories, and point-of-care settings. These diagnostics provide effective solutions for early disease detection, monitoring of treatment efficacy, and outbreak control, ensuring…
More Releases for Neuropathic
Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which…
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others.
The Neuropathic Ocular Pain market…
Global Neuropathic Pain Market Research Report Forecast to 2023
Neuropathic Pain Market 2020 comprises a detailed survey of the Neuropathic Pain Market size, share, trends, extension, consumption, and share, segments, application and Forecast 2025.
Global "Neuropathic Pain" Market 2020-2025 Report contains all demographic as well as analytical data regarding market review, growth, demand, and budget analysis. The report mainly highlights the significant trends of the Neuropathic Pain market in terms of thriving companies, business methods, product values and pricing, revenue,…
Neuropathic Pain Market grows with rising geriatric population
Global Neuropathic Pain Market: Overview
Neuropathic pain refers to a condition of chronic pain that is caused by a primary lesion such as trauma, infection, or other dysfunction in the nervous system. Prominent syndromes of neuropathic pain include root avulsions, postherpetic neuralgia, painful traumatic mononeuropathy, painful polyneuropathy, postsurgical pain syndromes, central pain syndromes, and complex regional pain syndrome. Some of the usual medications prescribed for neuropathic pain are anesthetics, anticonvulsants (also…
